- Home
- CNVS vs CVKD Comparison
CNVS vs CVKD Comparison
Compare CNVS & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNVS
- CVKD
- Stock Information
- Founded
- CNVS 2000
- CVKD 2022
- Country
- CNVS United States
- CVKD United States
- Employees
- CNVS N/A
- CVKD N/A
- Industry
- CNVS Consumer Electronics/Video Chains
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- CNVS Consumer Discretionary
- CVKD Health Care
- Exchange
- CNVS Nasdaq
- CVKD Nasdaq
- Market Cap
- CNVS 22.8M
- CVKD 26.3M
- IPO Year
- CNVS 2003
- CVKD 2023
- Fundamental
- Price
- CNVS $3.20
- CVKD $15.66
- Analyst Decision
- CNVS Buy
- CVKD Strong Buy
- Analyst Count
- CNVS 1
- CVKD 2
- Target Price
- CNVS $10.00
- CVKD $46.00
- AVG Volume (30 Days)
- CNVS 490.5K
- CVKD 81.0K
- Earning Date
- CNVS 11-14-2024
- CVKD 11-07-2024
- Dividend Yield
- CNVS N/A
- CVKD N/A
- EPS Growth
- CNVS N/A
- CVKD N/A
- EPS
- CNVS N/A
- CVKD N/A
- Revenue
- CNVS $45,005,000.00
- CVKD N/A
- Revenue This Year
- CNVS $31.52
- CVKD N/A
- Revenue Next Year
- CNVS N/A
- CVKD N/A
- P/E Ratio
- CNVS N/A
- CVKD N/A
- Revenue Growth
- CNVS N/A
- CVKD N/A
- 52 Week Low
- CNVS $0.72
- CVKD $5.40
- 52 Week High
- CNVS $3.93
- CVKD $32.55
- Technical
- Relative Strength Index (RSI)
- CNVS 68.21
- CVKD 50.92
- Support Level
- CNVS $2.48
- CVKD $16.25
- Resistance Level
- CNVS $3.30
- CVKD $19.97
- Average True Range (ATR)
- CNVS 0.33
- CVKD 1.91
- MACD
- CNVS -0.01
- CVKD -0.18
- Stochastic Oscillator
- CNVS 69.23
- CVKD 27.81
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.